HZNP News and Press, Horizon Therapeutics Public Limited Company From 05/16/23

2023-05-16 10:25:23 ET Amgen ( NASDAQ: AMGN ) is expected to mount a "very aggressive" defense if the Federal Trade Commission files a lawsuit to block the $28 billion acquisition of Horizon Therapeutics ( NASDAQ: HZNP ), according to CNBC. FTC commissioners have not y...

2023-05-16 10:07:34 ET Gainers: Phio Pharmaceuticals ( PHIO ) +30% . Coya Therapeutics ( COYA ) +23% . Nanobiotix ( NBTX ) +12% . Savara ( SVRA ) +12% . Bellerophon Therapeutics ( BLPH ) +11% . Losers: Eloxx Pharmaceutical...

2023-05-16 08:41:41 ET Seagen ( NASDAQ: SGEN ), which agreed to be sold to Pfizer ( NYSE: PFE ) in a $43 billion deal in March, fell 5.3% in premarket trading amid reports that the Federal Trade Commission was set to challenge Amgen's ( AMGN ) $28 billion p...

2023-05-16 08:14:55 ET Horizon Therapeutics ( NASDAQ: HZNP ) plummeted 18% in premarket trading on reports that the Federal Trade Commission plans to challenge the company's $28 billion sale to Amgen ( NASDAQ: AMGN ). Amgen ( AMGN ) ticked up 0.6%. The FTC is e...

2023-05-15 20:46:12 ET Update 8:45pm : Adds Bloomberg reporting on FTC expected to sue to block deal. Horizon Therapeutics plunged 16% in after hours trading on a report that the Federal Trade Commission is preparing to file a lawsuit to block the company's $28 billion sale to A...

2023-05-15 19:23:12 ET Horizon Therapeutics plunged 15% in after hours trading on a report that the Federal Trade Commission is preparing to file a lawsuit to block the company's $28 billion sale to Amgen ( NASDAQ: AMGN ). The FTC had a closed door meeting on Friday where ...

2023-05-12 15:56:01 ET Horizon Therapeutics ( NASDAQ: HZNP ) rose 1% amid a report that a Federal Trade Commission closed door meeting on Friday is likely unrelated to the Amgen's ( AMGN ) planned acquisition. The meeting appears to be unrelated to the transaction, acc...

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked first in overall corporate reputation among U.S. patient groups who reported working with, or who were familiar with the company. The results are based on PatientView’s annual survey of 361 patient groups who evaluated ...

2023-05-05 13:25:07 ET Horizon Pharmaceuticals ( NASDAQ: HZNP ) quickly rose 1.1% on a report that Amgen's ( NASDAQ: AMGN ) planned acquisition is expected to close on May 23. Horizon ( HZNP ) employees were told to expect a deal close on May 23, according to a...

In accordance with Rule 2.12 of the Irish Takeover Panel Act, 1997, Takeover Rules, 2022 (the “ Irish Takeover Rules ”), Horizon confirms that, as of the close of business on March 31, 2023, Horizon’s issued ordinary share capital is comprised of 228,576,339 ordinary shar...